Comgest Growth Europe S GBP U AccRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 4.6 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Islamic Equity - Other | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 14/05/2024 | GBP 11.64 | |
Day Change | 0.34% | |
Morningstar Category™ | Islamic Equity - Other | |
IA (formerly IMA) Sector | Europe Including UK | |
ISIN | IE000V1NA3Z9 | |
Fund Size (Mil) 14/05/2024 | EUR 83.78 | |
Share Class Size (Mil) 14/05/2024 | GBP 1.05 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 1.27% |
Investment Objective: Comgest Growth Europe S GBP U Acc |
The investment objective of the Fund is to seek to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 10/03/2020 | ||
Pierre Lamelin 01/09/2013 | ||
Click here to see others | ||
Inception Date 13/02/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Euro 350 Shariah TR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe S GBP U Acc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 8.97 |
Novo Nordisk A/S Class B | Healthcare | 8.44 |
Linde PLC | Basic Materials | 7.45 |
Essilorluxottica | Healthcare | 5.31 |
Nestle SA | Consumer Defensive | 5.27 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe S GBP U Acc |